695 related articles for article (PubMed ID: 34062192)
1. Charge-switchable nanoparticles enhance Cancer immunotherapy based on mitochondrial dynamic regulation and immunogenic cell death induction.
Zhao M; Li J; Liu J; Xu M; Ji H; Wu S; Chen D; Hu H
J Control Release; 2021 Jul; 335():320-332. PubMed ID: 34062192
[TBL] [Abstract][Full Text] [Related]
2. Engineering nanoparticles boost TNBC therapy by CD24 blockade and mitochondrial dynamics regulation.
Zhao M; Li J; Chen F; Han Y; Chen D; Hu H
J Control Release; 2023 Mar; 355():211-227. PubMed ID: 36736908
[TBL] [Abstract][Full Text] [Related]
3. Blockage of the IDO1 pathway by charge-switchable nanoparticles amplifies immunogenic cell death for enhanced cancer immunotherapy.
Shi M; Zhang J; Wang Y; Han Y; Zhao X; Hu H; Qiao M; Chen D
Acta Biomater; 2022 Sep; 150():353-366. PubMed ID: 35843594
[TBL] [Abstract][Full Text] [Related]
4. Repolarizing Tumor-Associated Macrophages and inducing immunogenic cell Death: A targeted liposomal strategy to boost cancer immunotherapy.
Li C; Wang L; Li Z; Li Z; Zhang K; Cao L; Wang Z; Shen C; Chen L
Int J Pharm; 2024 Feb; 651():123729. PubMed ID: 38142016
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional Nanoparticles Boost Cancer Immunotherapy Based on Modulating the Immunosuppressive Tumor Microenvironment.
Li J; Zhao M; Sun M; Wu S; Zhang H; Dai Y; Wang D
ACS Appl Mater Interfaces; 2020 Nov; 12(45):50734-50747. PubMed ID: 33124808
[TBL] [Abstract][Full Text] [Related]
6. Polymeric indoximod based prodrug nanoparticles with doxorubicin entrapment for inducing immunogenic cell death and improving the immunotherapy of breast cancer.
Zang X; Song J; Yi X; Piyu J
J Mater Chem B; 2022 Mar; 10(12):2019-2027. PubMed ID: 35254372
[TBL] [Abstract][Full Text] [Related]
7. Nanodrugs mediate TAMs-related arginine metabolism interference to boost photodynamic immunotherapy.
Chen Y; Shu X; Guo JY; Xiang Y; Liang SY; Lai JM; Zhou JY; Liu LH; Wang P
J Control Release; 2024 Mar; 367():248-264. PubMed ID: 38272398
[TBL] [Abstract][Full Text] [Related]
8. Polarization of Tumor-Associated Macrophages by Nanoparticle-Loaded
Wei B; Pan J; Yuan R; Shao B; Wang Y; Guo X; Zhou S
Nano Lett; 2021 May; 21(10):4231-4240. PubMed ID: 33998789
[TBL] [Abstract][Full Text] [Related]
9. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
10. Functional Gadofullerene Nanoparticles Trigger Robust Cancer Immunotherapy Based on Rebuilding an Immunosuppressive Tumor Microenvironment.
Li L; Zhen M; Wang H; Sun Z; Jia W; Zhao Z; Zhou C; Liu S; Wang C; Bai C
Nano Lett; 2020 Jun; 20(6):4487-4496. PubMed ID: 32407113
[TBL] [Abstract][Full Text] [Related]
11. Utilizing chemotherapy-induced tumor RNA nanoparticles to improve cancer chemoimmunotherapy.
Su L; Pan W; Li X; Zhou X; Ma X; Min Y
Acta Biomater; 2023 Mar; 158():698-707. PubMed ID: 36563773
[TBL] [Abstract][Full Text] [Related]
12. Multifunctional biomimetic nanoparticles loading baicalin for polarizing tumor-associated macrophages.
Han S; Wang W; Wang S; Wang S; Ju R; Pan Z; Yang T; Zhang G; Wang H; Wang L
Nanoscale; 2019 Nov; 11(42):20206-20220. PubMed ID: 31621735
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional Redox-Responsive Nanoplatform with Dual Activation of Macrophages and T Cells for Antitumor Immunotherapy.
Zhang W; Liu X; Cao S; Zhang Q; Chen X; Luo W; Tan J; Xu X; Tian J; Saw PE; Luo B
ACS Nano; 2023 Aug; 17(15):14424-14441. PubMed ID: 37498878
[TBL] [Abstract][Full Text] [Related]
14. Synergistic reinforcement of immunogenic cell death and transformation of tumor-associated macrophages via an M1-type macrophage membrane-camouflaged ferrous-supply-regeneration nanoplatform.
Wang Y; Xu H; Wang D; Lu Y; Zhang Y; Cheng J; Xu X; Chen X; Li J
Acta Biomater; 2024 Jan; 174():358-371. PubMed ID: 38092253
[TBL] [Abstract][Full Text] [Related]
15. Photothermal MnO
Chen Z; Zhang Q; Huang Q; Liu Z; Zeng L; Zhang L; Chen X; Song H; Zhang J
Int J Pharm; 2022 Apr; 617():121578. PubMed ID: 35176333
[TBL] [Abstract][Full Text] [Related]
16. Tumor microcalcification-mediated relay drug delivery for photodynamic immunotherapy of breast cancer.
Jian H; Wang X; Song P; Wu X; Zheng R; Wang Y; Zhang H
Acta Biomater; 2022 Mar; 140():518-529. PubMed ID: 34923096
[TBL] [Abstract][Full Text] [Related]
17. Mitochondria-targeted and ultrasound-responsive nanoparticles for oxygen and nitric oxide codelivery to reverse immunosuppression and enhance sonodynamic therapy for immune activation.
Ji C; Si J; Xu Y; Zhang W; Yang Y; He X; Xu H; Mou X; Ren H; Guo H
Theranostics; 2021; 11(17):8587-8604. PubMed ID: 34373760
[No Abstract] [Full Text] [Related]
18. Visible-Light-Triggered Prodrug Nanoparticles Combine Chemotherapy and Photodynamic Therapy to Potentiate Checkpoint Blockade Cancer Immunotherapy.
Choi J; Shim MK; Yang S; Hwang HS; Cho H; Kim J; Yun WS; Moon Y; Kim J; Yoon HY; Kim K
ACS Nano; 2021 Jul; 15(7):12086-12098. PubMed ID: 34165970
[TBL] [Abstract][Full Text] [Related]
19. Delicaflavone reactivates anti-tumor immune responses by abrogating monocytic myeloid cell-mediated immunosuppression.
Li L; You W; Wang X; Zou Y; Yao H; Lan H; Lin X; Zhang Q; Chen B
Phytomedicine; 2023 Jan; 108():154508. PubMed ID: 36332384
[TBL] [Abstract][Full Text] [Related]
20. Phenolic immunogenic cell death nanoinducer for sensitizing tumor to PD-1 checkpoint blockade immunotherapy.
Xie L; Wang G; Sang W; Li J; Zhang Z; Li W; Yan J; Zhao Q; Dai Y
Biomaterials; 2021 Feb; 269():120638. PubMed ID: 33421711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
